Wang Qi-Hui, Cheng Shi, Han Chun-Yu, Yang Shuang, Gao Sheng-Rui, Yin Wan-Zhong, Song Wen-Zhi
Department of Stomatology, China-Japan Union Hospital, Jilin University, 126#Xiantai Street, Jingkai District, Changchun, 130031, PR China.
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, 430079, PR China.
Mater Today Bio. 2024 Dec 6;30:101381. doi: 10.1016/j.mtbio.2024.101381. eCollection 2025 Feb.
Cancer stands as a predominant cause of mortality across the globe. Traditional cancer treatments, including surgery, radiotherapy, and chemotherapy, are effective yet face challenges like normal tissue damage, complications, and drug resistance. Biomaterials, with their advantages of high efficacy, targeting, and spatiotemporal controllability, have been widely used in cancer treatment. However, the biocompatibility limitations of traditional synthetic materials have restricted their clinical translation and application. Natural cell-inspired biomaterials inherently possess the targeting abilities of cells, biocompatibility, and immune evasion capabilities. Therefore, cell-inspired biomaterials can be used alone or in combination with other drugs or treatment strategies for cancer therapy. In this review, we first introduce the timeline of key milestones in cell-inspired biomaterials for cancer therapy. Then, we describe the abnormalities in cancer including biophysics, cellular biology, and molecular biology aspects. Afterwards, we summarize the design strategies of cell-inspired antitumor biomaterials. Subsequently, we elaborate on the application of antitumor biomaterials inspired by various cell types. Finally, we explore the current challenges and prospects of cell-inspired antitumor materials. This review aims to provide new opportunities and references for the development of antitumor cell-inspired biomaterials.
癌症是全球主要的死亡原因。传统的癌症治疗方法,包括手术、放疗和化疗,虽然有效,但面临着正常组织损伤、并发症和耐药性等挑战。生物材料具有高效、靶向和时空可控性等优点,已被广泛应用于癌症治疗。然而,传统合成材料的生物相容性限制了它们的临床转化和应用。天然细胞启发的生物材料天然具有细胞的靶向能力、生物相容性和免疫逃避能力。因此,细胞启发的生物材料可以单独使用,也可以与其他药物或治疗策略联合用于癌症治疗。在这篇综述中,我们首先介绍了用于癌症治疗的细胞启发生物材料的关键里程碑时间线。然后,我们描述了癌症中的异常情况,包括生物物理学、细胞生物学和分子生物学方面。之后,我们总结了细胞启发的抗肿瘤生物材料的设计策略。随后,我们详细阐述了受各种细胞类型启发的抗肿瘤生物材料的应用。最后,我们探讨了细胞启发的抗肿瘤材料目前面临的挑战和前景。这篇综述旨在为抗肿瘤细胞启发生物材料的开发提供新的机遇和参考。